Efonidipine

Drug Profile

Efonidipine

Alternative Names: Finte™; Landel; NZ 105; Selefodipine

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nissan Chemical Industries
  • Developer Nissan Chemical Industries; Shionogi; Zeria
  • Class Antihypertensives; Dihydropyridines; Nitrophenols; Organophosphorus compounds
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Angina pectoris; Hypertension
  • Discontinued Cerebrovascular disorders

Most Recent Events

  • 01 Jul 2003 Launched for Angina pectoris in South Korea (PO)
  • 01 Jul 2003 Launched for Hypertension in South Korea (PO)
  • 13 Feb 2001 A.S.A.C. Pharma is the licensee for Spain
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top